Navigation Links
AIT Laboratories Expands Pharma Services
Date:9/22/2008

Names Industry Veteran as Executive Director

INDIANAPOLIS, Sept. 22 /PRNewswire/ -- AIT Laboratories, a leading forensics, pain management, clinical, and pharmaceutical testing facility, is announcing the expansion of its pharmaceutical services and has chosen an industry veteran to lead the division. AIT has named Ronald Shoup, former co-founder and chief scientific officer of West Lafayette-based Bioanalytical Systems, Inc. (Nasdaq: BASI), as its executive director of Pharma Services. "Ron brings 30 years of leadership, entrepreneurship, and scientific expertise to AIT as we look to expand our facility to meet the growing needs of the Pharma industry," said AIT President and CEO Michael A. Evans, Ph.D.

AIT supports clinical trials through its current drug analysis services and expects to offer regulated bioanalytical services for preclinical development in the future. Almost 20 years of experience in sample management enables AIT to offer the highest quality of organization for the collection, distribution, maintenance, and reconciliation of samples from clinical studies. As a premier leader in the application of mass spectrometry for biological samples, AIT routinely develops, validates, and performs mass spectrometry analysis in support of new drug development.

"My experience in analytical chemistry, regulatory audits, and the Pharma/biotech industry has given me challenging opportunities to solve scientific problems in drug development," said Shoup. "I know that my skills can help AIT to further enhance its success and reputation in the industry."

As pharmaceutical companies are going more towards their core business of making drugs, AIT is filling a need of providing superior bioanalytical testing in support of clinical trials. "Pharmaceutical companies are demanding high-quality, bioanalytical testing, analyses of biological samples, regulatory compliance, a commitment to quality assurance, robust methods development, and state-of-the-art technology," said AIT Chief Scientific Officer Andrea Terrell, Ph.D. "AIT provides all of these services to our clients."

AIT is a company that boasts an impressive collection of more than 100 bioanalytical assay methods, which identify over 300 drugs using some of the most advanced instrumentation in the industry. Through the innovations of its dedicated staff and scientists using multiple mass spectrometers and tandem mass spectrometer detectors coupled with GC, HPLC, and UPLC chromatography systems, AIT has seen phenomenal growth in its current markets over the past several years and is now using that success to further pursue the pharmaceutical industry. "I loved the growth story at AIT, and it was obvious to me that the company's culture and flexibility has allowed it to respond to its fast-growing markets," said Shoup.

About AIT Laboratories:

AIT Laboratories, headquartered in Indianapolis, Ind., is an independent reference laboratory that is a premiere testing and research institution recognized nationwide for superior customer service and quality in testing. In 2008, AIT was named one of the "Best Places to Work in Indiana" by the Indiana Chamber of Commerce. In 2007 and 2008, AIT was recognized by Inc. magazine as one of the top 5,000 fastest-growing, private companies in the nation. Learn more about AIT Laboratories at http://www.aitlabs.com .

Contact: Raquel Bahamonde

Executive Director of Corporate Communications, AIT Laboratories

Phone: (317) 243-3894, ext. 476

Cell: (317) 308-0064

E-mail: rbahamonde@aitlabs.com Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Andrea Terrell https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=72455 Michael Evans https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=72454


'/>"/>
SOURCE AIT Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Appoints Singapore Laboratories Managing Director
2. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Stiefel Laboratories Appoints Two New Members to Board of Directors
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
7. ARUP Laboratories Releases ARUP Consult(R) 2.0
8. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
9. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
10. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... The 2017 Colorado Manufacturing Awards ... 30 nominees and well as the first-year award for 2017 Manufacturing Women of ... was hosted by CompanyWeek and Manufacturers Edge, among other sponsors. , The ...
(Date:4/21/2017)... ... April 21, 2017 , ... Frederick ... a range of emerging bio and technology start-ups, is hosting “Celebration Friday” (a ... double event will start with libations and networking at 3:30 p.m. at FITCI’s ...
(Date:4/20/2017)... ... April 20, 2017 , ... USDM Life Sciences , the ... and healthcare industries, is pleased to announce Holger Braemer as Vice President ... Europe GmbH” based in Germany. , Braemer is an integral part of USDM’s ...
(Date:4/20/2017)... ... April 20, 2017 , ... Parallel6™ , the leader ... announced today that they were named one of the 2017 Top 10 eClinical ... developments in the pharmaceutical industry. , “We take pride in honoring Parallel6 as one ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):